Friedreich's Ataxia Research Alliance Grant Program


Announcement "closed"
I'm interested
Organization:
Friedreich’s Ataxia Research Alliance (FARA)
Category:
Altres
Scope:
International
Start:
Internal deadline:
Official deadline:
Amount:
Segons Beca
Description:

The Friedreich's Ataxia Research Alliance (FARA) supports competitive research funding to advance therapeutic development for Friedreich's ataxia (FA).

FARA offers several funding schemes, including:

  • General Research Grant: Up to $125,000/year for 1-2 years, supporting basic, clinical, or translational research related to Friedreich's ataxia.

  • Keith Michael Andrus Cardiac Award: Up to $125,000/year for 1-2 years, focusing on the cardiac manifestations of the disease.

  • Kyle Bryant Translational Research Award: Up to $200,000/year for 1-2 years, supporting the development of new therapeutic strategies.

  • Bronya J. Keats Collaboration Award: Up to $175,000/year for 1-2 years, promoting collaborative research projects between research groups.

  • Peter Crisp AIM: Up to $100,000 for one year, supporting innovative, high-risk research projects with significant potential impact.

Additionally, FARA offers career development funding opportunities for early-career researchers, including clinician-scientists, postdoctoral researchers, and PhD students.

The calls generally follows a two-stage process with a Letter of Intent (LOI) followed by a full application. Several funding instruments are available, including research grants, translational awards, collaboration awards and career development opportunities for clinicians and postdoctoral researchers.

Objective: To advance therapeutic development for Friedreich's ataxia through the funding of high-quality basic, translational and clinical research.

Requirements

Applications are accepted from researchers worldwide.

  • Academic and for-profit investigators are eligible.
  • Eligible organisations include public and private universities, colleges, hospitals, laboratories, government agencies, biotechnology companies, pharmaceutical companies and other eligible for-profit entities.
  • Research projects must align with the scientific priorities of the FARA Grant Program in Friedreich's ataxia.
  • Geographic restrictions: none specified; applications are accepted from all countries.
  • Consortium requirements: Not specified in the call documentation.
Request

In case of interest, please click on 'm'interessa' and we will contact you.